NeuroVive Pharmaceutical AB Receita
Qual é o Receita de NeuroVive Pharmaceutical AB?
O Receita de NeuroVive Pharmaceutical AB é kr79.000k
Qual é a definição de Receita?
Receita é a renda que uma empresa tem de suas atividades comerciais normais, geralmente da venda de bens e serviços aos clientes.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Receita de empresas na Setor Health Care em OTC em comparação com NeuroVive Pharmaceutical AB
O que NeuroVive Pharmaceutical AB faz?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas com receita semelhantes a NeuroVive Pharmaceutical AB
- Caravel Minerals tem Receita de AUD$76.264k
- Lodestar Minerals tem Receita de AUD$77.250k
- Checkpoint Therapeutics Inc tem Receita de $78.000k
- E2 Metals tem Receita de AUD$78.000k
- Sahara tem Receita de CAD$78.033k
- Gold Reserve tem Receita de $78.294k
- NeuroVive Pharmaceutical AB tem Receita de kr79.000k
- Paradigm Biopharmaceuticals tem Receita de AUD$79.224k
- Inhibikase Therapeutics tem Receita de $79.570k
- PuriflOH tem Receita de AUD$79.729k
- Basin tem Receita de AUD$79.935k
- Greencoat Renewables PLC tem Receita de €80.000k
- Venture Minerals tem Receita de AUD$80.000k